Esketamine as an Antidepressant Posted by By Mike Bereza May 22, 2019Posted inDigital Health, New Medicines, Psychedelic-Assisted Psychotherapy, PsychedelicsNo Comments Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen…
